FDA SCRUTINIZES OFF-LABEL PROMOTIONS

被引：7

|

作者：

RANDALL, T

机构：

来源：

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 1991年 / 266卷 / 01期

关键词：

D O I：

10.1001/jama.266.1.11

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：11 / 11

页数：1

相关论文

共 50 条

[1] FDA unveils plans for "off-label" mailings
不详
ONCOLOGY-NEW YORK, 1998, 12 (07): : 968 - 968
[2] FDA off-track on off-label drug promotion
不详
LANCET, 2007, 370 (9604): : 1976 - 1976
[3] FDA publishes final rule on off-label information
Barlas, S
ONCOLOGY-NEW YORK, 1999, 13 (02): : 150 - 150
[4] From off-label prescribing towards a new FDA
Tabarrok, Alex
MEDICAL HYPOTHESES, 2009, 72 (01) : 11 - 13
[5] US FDA ordered to allow off-label data dissemination
Ault, A
LANCET, 1998, 352 (9127): : 555 - 555
[6] Off-label reprints still a hot issue in FDA reform
Kreeger, KY
SCIENTIST, 1997, 11 (02): : 1 - &
[7] Court rules that FDA cannot restrict off-label marketing
Roehr, Bob
BMJ-BRITISH MEDICAL JOURNAL, 2015, 351
[8] FDA recommends against off-label sildenafil use in children
Reactions Weekly, 2012, 1418 (1) : 2 - 2
[9] FDA Regulation of Off-label Drug Promotion Under Attack
Kesselheim, Aaron S.
Mello, Michelle M.
Avorn, Jerry
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 309 (05): : 445 - 446
[10] FDA warns against off-label use of antipsychotic drugs
Huntzinger, A
AMERICAN FAMILY PHYSICIAN, 2005, 71 (11) : 2205 - 2205

← 1 2 3 4 5 →